Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG effects on the endothelial glycocalyx in kidney transplant recipients
NL-OMON34735Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2010
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of antithymocyte globulin in kidney allograft rejection, sponsored by Amsterdam University Medical Center. Primary endpoint: Thickness of the endothelial glycocalyx. Planned start Feb 2010; status: not yet recruiting.
02
Drugs
antithymocyte globulin
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on NL-OMON34735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34735.